The evidence leans constructive4 supporting, 2 against, 0 worth knowing
Supporting
trading 15% above its 200-day average
matches long tail above — rejected higher, which has beaten the market by +0.39 points over 20 sessions across 16,308 past signals
3 independent kinds of evidence agree today, which is uncommon
revenue grew 24% year on year in the quarter ending 2026-06-30
Against
down 4% over twelve months
1 of the scans it matches has historically underperformed the market
Worth knowing
nothing the data supports either way
What would change this read: a close below 957, its 200-day average.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
What is working, what is not
read from the filings, with the figure behind every line
Working3
Revenue +29.8% year on year, Rs 198 cr to Rs 258 cr.
+29.8%Rs 198 crRs 258 cr
Borrowings are 0.02 times owners' equity, Rs 24 cr against Rs 1,115 cr.
0.02Rs 24 crRs 1,115 cr
Net profit +23.7% year on year, Rs 17 cr to Rs 21 cr.
+23.7%Rs 17 crRs 21 cr
Needs watching1
Operating cash flow was only Rs -21 cr against Rs 70 cr of reported profit, -30% of it.
Rs -21 crRs 70 cr-30%
Every figure here is computed from the company’s own filings. The wording is generated directly from the figures.
How it has performed
price return over each window, measured against zero
What the scans say today
7 of 47 matched on 2026-08-21
TTKHLTCARE matches 7 of the 47 scans today, across 3 different kinds of evidence. Three or more independent families agreeing is uncommon — it is the same test the shortlist on every page uses.
segments and revenue mix, as the company reports them
TTKHLTCARE reports 6 business segments. The largest is Consumer Products at 30% of revenue in the quarter ending 2026-06-30.
SegmentRevenueSharevs a year ago
Consumer Products77 cr29.9%—
Protective Devices73 cr28.2%—
Foods38 cr14.8%—
Animal Welfare36 cr13.9%—
Medical Devices34 cr13.0%—
Others0 cr0.0%—
Segment names are the company’s own, taken verbatim from the reportable-segment disclosure in its quarterly XBRL filing. Nothing on this page describes the business in words we wrote.
Quality of the business
balance sheet as at 2026-03-31
Return on equity
6.3%
trailing profit over shareholders’ funds
Return on capital
8.3%
pre-tax profit over equity plus borrowings
Debt to equity
0.02×
24 cr borrowed against 1,115 cr of equity
Net debt
2 cr
borrowings less cash
Cash conversion
-30%
operating cash flow as a share of profit
Receivable days
45
how long customers take to pay
Return on capital uses profit before tax over equity plus borrowings. The textbook version adds finance costs back; those are not tagged reliably in quarterly filings, so this understates the ratio for a heavily borrowed company rather than flattering it. Balance sheets are filed half-yearly, so these can be up to six months behind the profit figures above.
Valuation against its own history
500 sessions since 2024-09-06
16×
median 20×
30×
now 22×
TTKHLTCARE trades at 22× trailing earnings, above its median of 20× over this window — 11% more expensive than usual. The band runs from the 5th to the 95th percentile, so single-day spikes do not set the edges.
This window is short by the standards of valuation history — it begins where four quarters of filed earnings first exist. A stock can look cheap against two years and expensive against ten.
Board meeting filings were typically -0.04pt vs the market over the next 5 sessions (n=5,458) · AGM / EGM filings were typically +0.00pt vs the market over the next 5 sessions (n=4,362)
The business
from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
revenue grew 24% against the same quarter a year earlier
revenue rose in 4 of the last 4 quarters
Going against it
profit dropped 33% year on year
net margin narrowed from 10.0% to 8.3%
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q1 FY27
2026-06-30 · standalone
258
29
21
15.06
8.3%
Q4 FY26
2026-03-31 · standalone
218
30
22
15.40
10.0%
Q3 FY26
2025-12-31 · standalone
209
14
11
7.45
5.0%
Q3 FY25
2024-12-31 · standalone
205
23
17
11.84
8.2%
Q2 FY25
2024-09-30 · standalone
198
23
17
12.17
8.7%
Q1 FY25
2024-06-30 · standalone
208
41
32
22.35
15.2%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average+10.4%
Versus 200-day average+15.2%
Below 52-week high-7.6%
Above 52-week low+49.1%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)59.0
Higher closes in last 51 of 5
Six-month return+20.30%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.
Typical daily swing (ATR)5.30%
Volume versus 20-day0.9x
Median daily turnoverRs 3.2 cr
Recent sessions
what this stock has matched since the engine went live
This is the live record, not the backtest — the scans this stock actually appeared in on each stored session. A name that keeps reappearing is in a persistent condition; a one-day appearance usually is not.
Session
Scans
Which
2026-08-21
1
Golden cross — 50 crossed above 200
2026-08-20
2
Golden cross — 50 crossed above 200, MACD just turned negative